A

accountability and management

Accountable Authority

acquired fibrinogen deficiency

acquired hypogammaglobulinaemia

acronyms and abbreviations list

administered finances

administrative tribunal decisions

advertising and market research

age demographic of staff

agency resource statements

annual performance reporting statement

annual reports

Anti-D (Rh D immunoglobulin)

apheresis plasma

assets and asset management

Audit and Risk Committee

audit report

Australian Bleeding Disorders Registry (ABDR)

Australian Commission on Safety and Quality in Health Care (ACSQHC)

Australian Haemophilia Centre Directors' Organisation (AHCDO)

Australian Haemophilia Nurses Group

Australian Haemovigilance Minimum Data Set

Australian Information Commissioner

Australian National Audit Office (Auditor-General)

Australian Public Service Commission Employee Census

Australian Red Cross Lifeblood

awards

B

balance sheet

Bio-Rad Laboratories Pty Ltd

bleeding disorders (haemophilia)

Blood 2019 Awards

blood cells, see red blood cells

blood donors

Blood Management Standard, 75

Blood Service, see Australian Red Cross Lifeblood

BloodNet

BloodNet-Laboratory Information System interface

BloodSafe eLearning Australia

BloodSTAR

Board

budget, see finance

bushfires

Business Committee

Business Continuity Plan

Business Plan

C

C1 Esterase inhibitor

Canadian Bleeding Disorders Registry

capability reviews

Chief Executive (General Manager)

chronic inflammatory demyelinating polyneuropathy (CIDP)

classification of staff

Clinical Criteria for the use of Ig in Australia

clinical demand, see demand

clinical practice guidelines

clotting factors

Comcare, reportable incidents lodged with

Commonwealth Ombudsman

communication and promotion

competitive tendering and contracting

conferences and events

consultants

contingency planning

contracts, see purchasing

Corporate Plan

Council of Australian Governments (COAG)

COVID-19

Criteria for the clinical use of intravenous immunoglobulin in Australia

critical bleeding/massive transfusion PBM module

critical care PBM module

CSL Behring Pty Ltd

D

data developments

Deed of Agreement, Red Cross

Delaforce, Alana

demand

Department of Health

Deputy Chief Executives

diagnostic reagent products

disability reporting

discards, see wastage and discards

donors and donor management

E

ecologically sustainable development

education and training

emicizumab

employees

enterprise agreement

environmental performance

establishment of NBA

Executive Management Team

exempt contracts

expenditure, see finance

extended half-life recombinant factor products

external scrutiny

F

Factor VIIa

Factor VIII (rFVIII) products

Factor IX (rFIX) products

finance

financial assets

financial statements

fractionation, see plasma and recombinant products

fraud control

freedom of information

fresh blood

full-time employees

G

gender of employees

General Manager, see Chief Executive

governance

grant programs

Grifols Australia Pty Ltd

Guideline on the prophylactic use of Rh D Immunoglobulin in pregnancy care

H

Haematology Society of Australia and New Zealand

haemophilia, see bleeding disorders

Haemophilia Foundation Australia

haemovigilance

Haemovigilance Advisory Committee

horizon scanning

human resources

I

Immulab Pty Ltd

immunoglobulin (Ig)

income, see finance

Indigenous employees

information communication technology (ICT)

Information Publication Scheme statement

internal audit and risk program

internal auditors

international environment

inventory management

J

Johnson & Johnson Medical Pty Ltd

judicial decisions

Jurisdictional Blood Committee (JBC)

K

key performance indicators, see performance indicators/criteria

L

Laboratory Information Systems

Learnhub

legal decisions and actions

legislation

Lifeblood, see Australian Red Cross Lifeblood

location of employees

M

McMaster University

management and accountability

market research and advertising

maternity and obstetrics

medical PBM module

Medical Services Advisory Committee (MSAC)

Ministers

MyABDR patient portal

N

National Blood Account

National Blood Agreement

National Blood Authority Act 2003

National Blood Product Management Improvement Strategy 2018–22

National Blood Sector Research and Development Program

National Blood Sector Research and Development Strategic Priorities

National Blood Supply Contingency Plan

National Fractionation Agreement for Australia

National Haemovigilance Reports

National Immunoglobulin Governance Advisory Committee (NIGAC)

National Immunoglobulin Governance Program

National Managed Fund (Blood and Blood Products) Special Account

National Patient Blood Management (PBM) Guidelines

National Patient Blood Management Implementation Strategy

National Policy: Access to Government Funded Immunoglobulin Products in Australia

National Product Price List

National Reports on the Issue and Usage of Immunoglobulin

National Safety and Quality Health Service Standards

National Supply Plan and Budget (NSP&B)

neonatal and paediatric PBM module

new products, evaluation of

non-English speaking backgrounds, employees from

non-financial assets

non-ongoing employees

non-salary benefits

Novo Nordisk Pharmaceuticals Pty Ltd

NPS Medicinewise

O

Obizur

objectives

obstetrics and maternity

occupational health and safety

Office of the Australian Information Commissioner

Ombudsman

ongoing employees

online services, see information communication technology

operating result

organisation and structure

organisation charts

Ortho-Clinical Diagnostics

Output Based Funding Model (OBFM)

P

Parliamentary committees

part-time employees

pathology laboratories

patient blood management

Patient Blood Management Advisory Committee

Patient Blood Management (PBM) Guidelines

payables

people management

performance indicators/criteria

performance pay

performance reporting statement

perioperative PBM module

Pfizer Australia Pty Ltd

Pinchon, Debbie

planning framework

plasma and recombinant products

plasma for fractionation

plasmapheresis, see apheresis plasma

platelets

policy and policy advice

Portfolio Budget Statement

prices

Pricewaterhouse Coopers Consulting (Australia) Pty Ltd

procurement, see purchasing

productivity gains

promotion and communication

Prothrombinex

provisions

Public Governance, Performance and Accountability Act 2013

Public Governance, Performance and Accountability Rule 2014

Public Service Act 1999

publications distributed

purchasing

purchasing of blood and blood product supply

R

recombinant products, see plasma and recombinant products

red blood cells

remuneration of staff

research and development

resource statements

returns to government

revenue, see finance

Rh D (Anti-D) immunoglobulin

RiaSTAP

risk management

role

S

safe and efficient use, see patient blood management

salary and remuneration

Sanofi-aventis Australia Pty Ltd

satisfaction with Lifeblood

savings

sector monitoring

security of supply, see supply

service charter

Shire Australia Pty Ltd

small business, procurement initiatives to support

special accounts

Specialist Working Groups

staff

Staff Participation Forum

Standard Operating Procedures (SOPs)

standards

STARS

Statement on National Stewardship Expectations for the Supply of Blood and Blood Products

statutory committees

Strategic Framework for the National Haemovigilance Program

supply

supply chain management, see inventory management

T

tenders, see purchasing

training, see education and training

tribunal decisions

V

values

W

wastage and discards

website services, see information communication technology

whole blood

work health and safety

workforce